|

Alpelisib + Pembrolizumab Clinical Trials

1 actively recruiting trial across 1 location

Also known as: BYL 719

Pipeline

Phase 1: 1

Top Sponsors

  • M.D. Anderson Cancer Center1

Indications

  • Brain Metastasases1
  • Melanoma (Skin Cancer)1
  • Breast Cancer1
  • Cancer1

Houston, Texas1 trial

Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA)

MD Anderson Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.